相关实验视频

Updated: May 6, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

内心大动脉的临床影响用于关节重整形手术

Cristina Barbero¹, Andrea Costamagna², Peter Verbrugghe³

¹Division of Cardiac Surgery, Cardiovascular and Thoracic Department, Città Della Salute E Della Scienza, University Hospital of Turin, Corso Bramante 88, 10126, Turin, Italy. cristina.barbero@unito.it.

Journal of cardiovascular translational research

|April 17, 2024

概括

带有体外循环 (EAC) 的右侧微型胸腔切除术为重复手术中膜 (MV) 患者提供了更好的结果. 与其他手术方法相比,这种方法导致心脏输出低综合征的发生率更低,住院时间更短.

科学领域:

心血管外科心血管外科
胸部外科手术胸部外科手术
最少侵入性心脏外科手术

背景情况:

重新修复 mitra 门手术提出了独特的挑战.
对于复杂的心脏手术,越来越多地探索微创方法.
对比不同的外科手术技术对于优化患者的治疗结果至关重要.

研究的目的:

为了比较通过右侧小胸腔切除术与体外循环 (EAC) 进行的复制 mitra 门手术的结果与其他手术方法.
评估EAC技术在重复手术中的安全性和有效性.

主要方法:

来自7个欧洲中心的216名重复手术患者的回顾性分析.
患者被分为两组:使用EAC的右侧小胸切除术和其他手术方法 (胸切除术,未扣紧的小胸切除术,用跨胸的小胸切除术).
主要终点:30天死亡率. 二级终点:中风,重新探索,低心力输出综合征 (LCOS),呼吸衰竭,重症监护室和住院时间.

主要成果:

三十天死亡率,中风,重新探索出血和断奶失败在各组之间是可比的.
在EAC群体中,LCOS的发生率明显较低 (p=0.03).
接受EAC的患者经历了显著更短的ICU (p=0.04) 和住院时间 (p=0.002).

结论:

带有EAC的右侧小胸切除术是一种安全有效的方法,用于重复中膜手术.
EAC技术促进了"无触摸"的大动脉操纵,可能有助于改善临床结果.
这种方法与LCOS减少和住院时间缩短有关,为患者的康复提供了显著的好处.

关键词:

中心门假体假体重新切胸术,粘附情况重新做,重做,重做,重做.逆行性动脉输液是指逆行性动脉输液.

更多相关视频

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

相关概念视频

Mitral Valve Prolapse II: Assessment and Management

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...

Mitral Regurgitation I: Introduction

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...

Mitral Regurgitation III: Medical Management

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...

Mitral Stenosis I: Introduction

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...